Skip to main content
Signal8

Vairavan Latha

SEC insider (Form 3/4/5 filer). CIK 0002065881. SVP Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT). 9 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in WESTLAKE VILLAGE, CA.

Companies Vairavan Latha has filed insider reports for

  • Arcutis Biotherapeutics, Inc. (ARQT): Officer, SVP Chief Financial Officer
Vairavan Latha profile photo

Vairavan Latha

CIK: 0002065881

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (77.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcutis Biotherapeutics, Inc. logo
ARQT

Arcutis Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    May 11, 2026
    Sale
    Direct
    435 shares at avg. $21.05$9K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    May 4, 2026
    Sale
    Direct
    1.3K shares at avg. $23.61$32K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Mar 2, 2026
    Sale
    Direct
    2.8K shares at avg. $25.16$70K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Mar 2, 2026
    Sale
    Direct
    81 shares at avg. $25.91$2K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Feb 27, 2026
    Award
    Direct
    27K shares-
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Feb 2, 2026
    Sale
    Direct
    1.3K shares at avg. $25.50$34K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 3, 2025
    Sale
    Direct
    88 shares at avg. $24.72$2K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Aug 4, 2025
    Sale
    Direct
    89 shares at avg. $14.33$1K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    May 6, 2025
    Award
    Direct
    20K shares-

1-9 of 9